CANADA LIFE ASSURANCE Co - IOVANCE BIOTHERAPEUTICS INC ownership

IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 127 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 0.37 and the average weighting 0.4%.

Quarter-by-quarter ownership
CANADA LIFE ASSURANCE Co ownership history of IOVANCE BIOTHERAPEUTICS INC
ValueSharesWeighting
Q3 2023$110
-2.7%
24,225
+52.2%
0.00%
Q2 2023$113
+121.6%
15,921
+90.9%
0.00%
Q1 2023$51
+4.1%
8,341
+8.7%
0.00%
Q4 2022$49
-99.9%
7,670
+4.6%
0.00%
Q3 2022$70,000
-11.4%
7,335
+2.3%
0.00%
Q2 2022$79,000
-35.8%
7,168
+2.2%
0.00%
Q1 2022$123,000
-5.4%
7,012
+2.4%
0.00%
Q4 2021$130,000
-21.7%
6,851
+2.3%
0.00%
Q3 2021$166,000
-4.6%
6,6980.0%0.00%
Q2 2021$174,000
-17.5%
6,6980.0%0.00%
-100.0%
Q1 2021$211,000
-36.4%
6,698
-6.4%
0.00%0.0%
Q4 2020$332,000
+40.7%
7,1580.0%0.00%0.0%
Q3 2020$236,000
+21.0%
7,1580.0%0.00%
Q2 2020$195,000
-9.7%
7,1580.0%0.00%
-100.0%
Q1 2020$216,000
+10.2%
7,1580.0%0.00%
Q4 2019$196,000
-44.8%
7,158
-50.8%
0.00%
-100.0%
Q2 2019$355,000
+157.2%
14,5380.0%0.00%
Q1 2019$138,000
+11.3%
14,5380.0%0.00%
Q4 2018$124,000
+27.8%
14,538
+67.4%
0.00%
Q3 2018$97,000
-12.6%
8,6850.0%0.00%
Q2 2018$111,000
-24.5%
8,6850.0%0.00%
Q1 2018$147,000
+19.5%
8,685
-44.1%
0.00%
Q4 2017$123,00015,5410.00%
Other shareholders
IOVANCE BIOTHERAPEUTICS INC shareholders Q2 2018
NameSharesValueWeighting ↓
MHR Fund Management 11,997,103$84,459,60511.88%
MPM BioImpact LLC 2,950,118$20,768,8314.18%
Perceptive Advisors 14,036,410$98,816,3262.86%
Velan Capital Investment Management LP 240,000$1,689,6001.57%
Parametrica Management Ltd 96,500$679,3601.31%
Boxer Capital, LLC 3,705,133$26,0841.21%
Soleus Capital Management, L.P. 1,239,777$8,728,0300.97%
Opaleye Management Inc. 421,000$2,963,8400.71%
683 Capital Management, LLC 1,400,000$9,856,0000.71%
RICE HALL JAMES & ASSOCIATES, LLC 1,758,759$12,381,6650.70%
View complete list of IOVANCE BIOTHERAPEUTICS INC shareholders